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Syphilis is an infectious disease caused by the bacterium Treponema pallidum. Syphilis has
three clinical stages and may present various oral manifestations, mainly at the secondary
stage. The disease mimics other more common oral mucosa lesions, going undiagnosed
and with no proper treatment. Despite the advancements in medicine toward prevention,
diagnosis, and treatment syphilis remains a public health problem worldwide. In this sense,
dental surgeons should be able to identify the most common manifestations of the disease
in  the oral cavity, pointing to the role of this professional in prevention and diagnosis. Thisecondary syphilis
reponema pallidum
study describes a case series of seven patients with secondary syphilis presenting different
oral  manifestations.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
thous ulcers or irregularly shaped lesions with whitish edgesntroduction
umans are the only natural host known to date of syphilis,
n infectious disease caused by the bacterium Treponema pal-
idum. This microorganism has positive tropism for several
uman organs and tissues, with complex clinical implications.
ransmission occurs mainly through unprotected sexual
ntercourse and although the main inoculation site is the gen-
tal organs in general, extragenital areas such as the oral cavity
nd the anal region are also affected.1–5 Other important trans-
ission pathways include the intra-uterus (transplacentary)oute during labor,1,4 which causes congenital syphilis.
Syphilis has three clinical stages. The primary stage is char-
cterized by a single chancre that manifests approximately 90
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days after exposure and remits spontaneously within two to
eight weeks. The secondary stage occurs between 2 and 12
weeks after exposure, when a rash develops on several parts
of the skin. The rash subsides spontaneously with no treat-
ment when the condition enters its latent stage. Also called
late phase and rarely observed today, the tertiary stage is char-
acterized by gummata and/or neurosyphilis that emerge three
years or later after exposure.1,3–10
Although oral manifestations of syphilis may be observed
at the primary stage, they are more  commonly detected at
the secondary stage of the disease as multiple painless aph-distributed on the oral mucosa and oropharynx, especially
on the tongue, lips, and jugal mucosa.4,6,9 The appearance
of such lesions varies widely, thus increasing the diagnostic
e under the CC BY-NC-ND license (http://creativecommons.org/
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Table 1 – Oral anatomical sites affected, type of fundamental lesion and differential diagnosis.
Oral anatomical site(s) affected Fundamental lesion Differential diagnosis
Patient 1
Male
45 years old
Married
A  – Upper lip mucosa near the
commissure
Ulcer and mucous plaque Lichen planus, pemphigus vulgaris
C – Tongue edge Nodule and ulcer Ulcer by trauma
B – Lip commissure Nodule and ulcer Angular cheilitis
Patient 2
Male
46 years old
Single
C  – Hard palate Ulcer Spinocellular carcinoma
A – Lower lip mucosa Mucous plaque Aphthous ulcer
B – Ventral tongue Mucous plaque Aphthous ulcer
Patient 3
Male
42 years old
Single
A/B  – Bilateral tongue edge Nodule Trauma by biting, ﬁbroepithelial
hyperplasia
Patient 4
Female
53 years old
Married
A/B  – Soft palate, involving tonsil pillars Nodule and ulcer Spinocellular carcinoma
(simultaneous)
Patient 5
Female
29 years old
Long term relationship
A  – Soft palate Mucous plaque Ulcer by trauma
A – Hard palate Mucous plaque Ulcer by trauma
B – Lower lip mucosa Spot and erosion Leukoplakia, lichen planus
Patient 6
Female
39 years old
Married
A/B  – Apex and edge of tongue, bilaterally Mucous plaque Pseudomembranous candidiasis,
lichen planus, pemphigus vulgaris
Patient 7
Female
A  – Uvula and palate tonsil Mucous plaque Ulcer by trauma, spinocellular
carcinoma36 years old
Long term relationship
complexity when the dental surgeon is not properly quali-
ﬁed to detect stomatological conditions. For this reason, oral
manifestations of syphilis may be mistaken for other, more
common oral conditions, with no early diagnosis or appropri-
ate treatment.
In addition to information obtained directly from the
patient during consultation, the diagnosis of syphilis normally
includes clinical examination and serological and microbio-
logical assays. As a rule, biopsy is only required when lesions
do not subside completely. Standard laboratory assays used to
diagnose syphilis at any stage include treponemal and non-
treponemal serum tests.3,9
Based on penicillin, the ﬁrst successful anti-syphilis treat-
ment was documented in 1943. Since then, penicillin is the
drug of choice to treat the disease, usually penicillin G benza-
thine or penicillin G procaine.1,6
This case series describes different oral manifestations of
secondary syphilis in seven heterosexual patients. The objec-
tive was to discuss the diagnosis and treatment protocols
adopted by the Stomatology Unit, Hospital de Clínicas de Porto
Alegre (HCPA), Rio Grande do Sul, Brazil and to characterize
secondary syphilis lesions in the oral cavity and the respective
clinical follow-up of patients toward cure.Clinical  cases  series
Herein we present seven patients with oral manifestations of
secondary syphilis that were referred to our Stomatology Unit.Table 1 shows the demographic data of the patients including
age group, gender, and marital status.
All patients were initially seen at primary healthcare cen-
ters complaining of multiple painful lesions in the mouth as
their main health problem, and went through the same med-
ical diagnostic protocol (Fig. 1). HIV and hepatitis C exams
requested were negative for all patients, and none admitted
drug addiction. The most common fundamental lesions were
plaques on the mucosa, ulcers, nodules, spots, and erosion,
in this order. The most affected anatomical sites included
labial mucosa, tongue edge, hard and soft palates, lip com-
missure, ventral tongue, uvula, and tonsils, respectively. Fig. 2
shows photographs of the oral lesions of each patient. The
most frequent diseases considered in the differential diagno-
sis were ulcers caused by trauma, spinocellular carcinoma,
and autoimmune diseases. Table 1 lists the oral sites affected,
the fundamental lesion type, and the differential diagnosis for
each lesion.
The venereal disease research laboratory (VDRL) test and
the ﬂuorescent treponemal antibody absorption (FTA-ABS)
test were carried out for all patients, which are convention-
ally requested to diagnose syphilis. Results of both tests are
shown in Fig. 3,11 while serological assay results are shown in
Table 2.
Upon conﬁrmation of the diagnosis of syphilis, all patients
received the conventional treatment as described by Brazilian
health authorities.12 This treatment includes intramuscular
injections of penicillin G benzathine 2,400,000 IU a week for
three weeks, and follow-up with serological assays until VDRL
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Clinical history and examination
Assays resquested
Serological (STD):
VDRL
Syphilis
Blood tests (for biopsy):
Hemogram
Glucose
Platelets
Prothrombin time
Activated partial thromboplastin time
Erythrocyte sedimentation rate
VDRL and FTA-ABS negativeVDRL and FTA-ABS positive
HIV
Hepatitis C
Penicilline G benzathine Incision biopsy for
anatomopathological and
immunofluorescence assays
Biopsy if lesions persist
STD prevention measures
Remittance of lesions: observe
periodical control
FTA-ABS
ELISA
Anti-HCV
Fig. 1 – Protocol to diagnose and treat syphilis.
Table 2 – Results of serological assays. Assays were  conducted at approximately 30-day intervals.
1st assay 2nd assay 3rd assay 4th assay 5th assay
Patient 1 VDRL – positive 1:1024
FTA ABS – positive
VDRL – positive 1:32
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
Patient 2 VDRL – positive 1:128
FTA ABS – positive
VDRL – positive 1:32
FTA ABS – positive
VDRL – positive 1:4
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
VDRL – positive 1:1
FTA ABS – positive
Patient 3 VDRL – positive 1:32
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
Patient 4 VDRL – positive 1:128
FTA ABS – positive
VDRL – positive 1:64
FTA ABS – positive
VDRL – positive 1:16
FTA ABS – positive
VDRL – positive 1:8
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
Patient 5 VDRL – positive 1:32
FTA ABS – positive
VDRL – positive 1:1
FTA ABS – positive
Patient 6 VDRL – positive 1:128
FTA ABS – positive
VDRL – positive 1:32
FTA ABS – positive
VDRL – positive 1:4
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
Patient 7 VDRL – positive 1:16
FTA ABS – positive
VDRL – positive 1:2
FTA ABS – positive
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e oraFig. 2 – Photographs of th
titers are reduced. Patients are also instructed as to the impor-
tance of safe sexual practices, the risk of reinfection when
sexual partners are not treated for the disease, and the risk of
acquiring HIV and other STDs.
Oral manifestations of secondary syphilis disappeared
completely within one to two weeks after the ﬁrst penicillin
injection avoiding the need to carry out biopsy.Discussion
STDs are among the main public health problems, causing
increasing concern worldwide.13 Approximately 12,000,000l lesions of each patient.
new cases worldwide are estimated to occur every year.14
Syphilis stands out as an important epidemiological marker
in the investigation of other STDs, mainly HIV infection.15 In
Brazil, an estimated 900,000 new cases are diagnosed every
year.16
Two types of syphilis have been described. Congenital
syphilis is vertically transmitted, while the acquired form of
the disease is an STD.3,4 Acquired syphilis has three clearly
distinct clinical stages, called primary, secondary, and ter-
tiary. In addition, the literature mentions a latent stage, which
comprises the timespan following infection with T. pallidum,
characterized by sero-reactivity and no other evidence of the
disease.1,4,5,7,8 All patients whose records were analyzed in the
b r a z j i n f e c t d i s . 2 0 1 
Interpretation of VDRL and FTA-ABS assays
VDRL positive and FTA-ABS positive: active or latent syphilis de sífilis ativa ou
sífilis latente
VDRL positive and FTA-ABS negative: other disease
VDRL negative and FTA-ABS positive: primary or treated syphilis
VDRL negative and FTA-ABS negative: syphilis if ruled out
Source: Brazilian Health Ministry, 2010
Note:  FTA-ABS result will remain positive for life, even when the patient is cured.
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nFig. 3 – Interpretation of VDRL and FTA-ABS assays.
resent study had been diagnosed with secondary syphilis,
hich is characterized by muco-cutaneous manifestations
nd by hematogenous dissemination that elicits the coloniza-
ion of several organs.1,17 This stage starts within three to
ve months after infection. However, if not treated, secondary
yphilis may recur as late as two years after exposure.18 It is
ccompanied by unspeciﬁc clinical signs and symptoms, such
s general discomfort, headache, low-grade fever, anorexia,
eight loss, and lymphadenopathy.4,9,17,18 Pharyngitis, myal-
ia, and arthralgia may also be present.9 These conditions
isappear spontaneously, with no treatment, during the latent
eriod.1,4,5,7,9
Oral manifestations of secondary syphilis include multi-
le, scattered lesions on the oral mucosa and oropharynx,
hough the tongue, lips, and jugal mucosa are the most com-
only affected sites. Aphthous ulcers similar to gray plaques
r ulcers with irregular, whitish edges that are painful at times
re also observed. The diffuse character of the inﬂamma-
ory process in the oropharynx may elicit complaints of sore
hroat.4,6,9 Oral lesions varies widely in appearance, increas-
ng the complexity of diagnosis if the dental surgeon lack the
equired qualiﬁcations in stomatology. In contrast to primary
yphilis, secondary syphilis in the oral cavity is not associated
ith oral sex habits.
The patients analyzed in the present study exhibited mul-
iple lesions in the oral cavity caused by syphilis with the
xception of patient 7, who exhibited a lesion in the uvula
nly. The lip mucosa and the tongue edge were the anatomical
ites most frequently affected (in four patients each), followed
y the hard and soft palates (in two patients each), ventral
ongue, lip commissure, uvula, and tonsils (in one patient
ach). The fundamental lesions most commonly detected
ere mucous plaque (in seven anatomical sites), ulcer (in ﬁve),
odule (in four), spot and erosion (in one site each) (Table 1).
Clinical history, physical examination, and serological
nd microbiological assays are usually sufﬁcient to diagnose
yphilis. The information obtained in the present case series
how that serological assays for syphilis should be requested
rom all suspected patients as a means to reach differential
iagnosis. Therefore, depending on the clinical manifestation,
ifferential diagnosis are trauma caused by bites, ﬁbroep-
thelial hyperplasia, lichen planus, pemphigus vulgaris, ulcer
ssociated with trauma, angular cheilitis, spinocellular carci-
oma, aphthous ulcers, and leukoplakia (Table 1). The variety6;2 0(4):393–398 397
of differential diagnosis in this case series conﬁrms the ﬁnd-
ings described in previous studies, that is, secondary syphilis
takes on several manifestations in the oral cavity, in which
case the disease mimics other more  frequent lesions in the
oral mucosa, occasionally proceeding along its course with no
proper diagnosis and treatment.1–4,8,9
The serology assays requested for the patients in the
present study included VDRL and FTA-ABS to investigate
syphilis, and enzyme-linked immunosorbent assay (ELISA)
for HIV and HCV. All patients had positive VDRL and FTA
ABS results (Table 2), conﬁrming the diagnosis of secondary
syphilis. The results of HIV and HCV tests were all negative.
It has been shown that patients with syphilis are at higher
risk of acquiring other STDs, especially HIV infection, since
the syphilitic lesions are suitable sites for the virus to enter
the human body.6 This highlights the importance of instruct-
ing patients as to preventive measures concerning safe sexual
behavior, appropriate medical treatment of partners diag-
nosed positive for any relevant disease, and the awareness of
the risks around sharing needles.
Treponemal and non-treponemal assays are the standard
laboratory tests used to detect the presence of syphilis at
any stage.3,9 Results of positive non-treponemal assays are
reported as the lowest positive dilution. These assays are
suitable for evaluating response to treatment and to assess
the likelihood of reinfection. However, these tests are not
indicated during the latent stage of the disease due to their
poor sensitivity.18 These assays include the VDRL and its
simpliﬁed version, the rapid plasma regain (RPR) test.3,9 Due
to their increased speciﬁcity and sensitivity, the treponemal
assays Treponema pallidum particle agglutination assay (TPPA),
the FTA-ABS assay, and ELISA are used mainly as diagnosis
conﬁrmation tools.3,9 However, these tests do not clarify activ-
ity of the disease and, in most cases, will always remain
positive, even after successful treatment.18
In a systematic review and meta-analysis, the sensitivity
and speciﬁcity of fast treponemal assays were shown to be
comparable to those of standard methods.19 The authors con-
cluded that when resources are limited (that is, when access
to laboratories is difﬁcult and screening for syphilis is not con-
ducted), the fast detection assays are useful alternatives.
The ﬁrst effort to treat syphilis was successfully conducted
in 1943, using penicillin, which has since retained its status
as drug of choice for treating of all stages of syphilis. Both
penicillin G benzathine or penicillin G procaine are used for
this purpose.1,6 The Brazilian Ministry of Health deﬁnes a sin-
gle 2,400,000 IU intramuscular dose of penicillin G benzethine
as the treatment of choice for both primary and secondary
syphilis. However, the tertiary stage of the disease is treated
with the same dose, repeated weekly for three weeks.5,12 Due
to the difﬁculty to determine whether secondary syphilis in
the cases evaluated was at the early or late stages, the treat-
ment for late secondary syphilis was adopted in order to
improve the chances of success.
For patients hypersensitive to penicillin, oral adminis-
tration of doxycycline 100 mg  twice a day for 14 days or
tetracycline 500 mg  four times a day for 14 days is indicated,
with similar efﬁcacy. These regimens are effective to treat pri-
mary, latent secondary, and early secondary stages of syphilis.
Cases estimated to be in progress for one year or more (or
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when it is not possible to establish date of infection), treat-
ment duration is increased to 28 days, either with doxycycline
or tetracycline.1,5
Evidence indicates that azithromycin 1 g a week for two
to three weeks is effective to treat syphilis in penicillin-
hypersensitive patients. However, the specialized literature
warns that resistance to azithromycin has emerged quickly.9
Although the treatment protocols for syphilis have been
clearly deﬁned, few randomized clinical studies have been
conducted to ascertain whether azithromycin or penicillin
G are more  effective to treat early syphilis. For each indi-
vidual case, the decision to prescribe one or other of these
drugs should be based on an evaluation of the cost–beneﬁt
relationship and on any risks the patient may have to face.3
A systematic review has recommended that azithromycin
should be prescribed to treat early syphilis, though it has to
be considered an alternative approach when the patient has
hypersensitivity to penicillin or doxycycline is not a feasible
option.20 The records of all patients analyzed in the present
study show that none had such hypersensitivity.
Conclusion
In spite of the advances in medicine toward the prevention and
early diagnosis and treatment of syphilis, the disease remains
a public health problem worldwide. The growing prevalence
of the disease in immunocompetent individuals is reason
for concern, indicating poor compliance with safe sex prac-
tices to prevent STDs. Primary syphilis may be observed in
the oral cavity, and has been associated with oral sex. The
secondary stage of the disease takes a variety of oral mani-
festations, mimicking other more  frequent lesions in the oral
cavity, going by undetected and hence remaining without
proper treatment. The analysis of a suspected patient’s clinical
history, combined with physical examination and serological
assays normally affords a conclusive diagnosis of the disease,
and biopsy is not normally required as an initial diagnostic
resource. Therefore, the dental surgeon should be aware of the
most common manifestations of syphilis in the oral mucosa
so as to play a role not only in the treatment of syphilis, but
also in the diagnosis of the disease.
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